Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market. The ...

Bio-Rad claims that, Bio-Plex Pro magnetic bead-based human and mouse cytokine assays are multiplex assays that offer can fast performance for the detection of multiple biomarkers in a single ...

Bio-Rad. Detecting changes in apolipoprotein levels can be difficult with traditional ELISA techniques because they require a large sample input. The Bio-Plex Pro Apolipoprotein Panel offers a ...

Bio-Rad Laboratories, Inc. (CA, USA) (NYSE: BIO and BIOb) is announcing the launch of the Reliance One-Step Multiplex Supermix, a highly sensitive and robust reagent mix for detection and ...

Bio-Rad Laboratories and Myriad RBM have partnered to develop and distribute immunoassay kits. The agreement combines Myriad RBM’s menu of multiplexed immunoassays with Bio-Rad’s global ...

In February 2021, the company received the FDA’s EUA for a COVID-19, influenza A and influenza B RT-PCR syndromic multiplex test. Earlier in January 2021, Bio-Rad received the FDA’s EUA for ...

This In Focus, supported by Bio-Rad Laboratories, will explore the challenges and advantages of multiplex PCR technologies and the tools being developed to overcome those challenges.

"The continued development of the Bio-Rad StarBright Dye portfolio, now totaling 28 dyes and spanning multiple lasers, gives researchers greater choice and flexibility across multiplex flow cytometry ...

Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels. In April 2022, Bio-Rad Laboratories introduced three new ...